COMPARISON OF THE OPSONIC AND COMPLEMENT ACTIVATING ACTIVITY OF HUMAN MONOCLONAL IGG AND IGM ANTIBODY AGAINST GROUP-B STREPTOCOCCI

被引：0
|
作者：
SHYU, SD
RAFF, HV
BOHNSACK, JF
KELSEY, DK
HILL, HR
机构：
[1] UNIV UTAH,DEPT PATHOL,SALT LAKE CITY,UT 84112
[2] UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84112
[3] MEAD JOHNSON RES CTR,EVANSVILLE,IN
来源：
PEDIATRIC RESEARCH | 1991年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：A185 / A185
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF THE OPSONIC AND COMPLEMENT TRIGGERING ACTIVITY OF HUMAN MONOCLONAL IGG1 AND IGM ANTIBODY AGAINST GROUP-B STREPTOCOCCI
    SHYUR, SD
    RAFF, HV
    BOHNSACK, JF
    KELSEY, DK
    HILL, HR
    JOURNAL OF IMMUNOLOGY, 1992, 148 (06): : 1879 - 1884
  • [2] OPSONIC ACTIVITY OF HUMAN-IGG AND IGM ANTIBODY FOR TYPE-III GROUP-B STREPTOCOCCI
    ANTHONY, BF
    CONCEPCION, NF
    PEDIATRIC RESEARCH, 1989, 26 (04) : 383 - 387
  • [3] FIBRONECTIN ENHANCES THE OPSONIC AND PROTECTIVE ACTIVITY OF MONOCLONAL AND POLYCLONAL ANTIBODY AGAINST GROUP-B STREPTOCOCCI
    HILL, HR
    SHIGEOKA, AO
    AUGUSTINE, NH
    PRITCHARD, D
    LUNDBLAD, JL
    SCHWARTZ, RS
    JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (06): : 1618 - 1628
  • [4] COMPARATIVE PROTECTIVE ACTIVITY OF HUMAN MONOCLONAL AND HYPERIMMUNE POLYCLONAL ANTIBODY AGAINST GROUP-B STREPTOCOCCI
    HILL, HR
    GONZALES, LA
    KNAPPE, WA
    FISCHER, GW
    KELSEY, DK
    RAFF, HV
    JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04): : 792 - 798
  • [5] A HUMAN IGG-3 IS OPSONIC INVITRO AGAINST TYPE-III GROUP-B STREPTOCOCCI
    KIM, JS
    KIM, KS
    WASS, CA
    SHORT, JA
    HEINER, DC
    JOURNAL OF CLINICAL IMMUNOLOGY, 1990, 10 (03) : 154 - 159
  • [6] COMPLEMENT IS REQUIRED FOR OPSONIZATION AND PROTECTION AGAINST TYPE-III GROUP-B STREPTOCOCCI BY HYBRIDOMA IGM ANTIBODY
    JENSEN, C
    SHIGEOKA, AO
    CLINICAL RESEARCH, 1983, 31 (01): : A118 - A118
  • [7] ROLE OF ANTIBODY AND COMPLEMENT IN OPSONIZATION OF GROUP-B STREPTOCOCCI
    SHIGEOKA, AO
    HALL, RT
    HEMMING, VG
    ALLRED, CD
    HILL, HR
    INFECTION AND IMMUNITY, 1978, 21 (01) : 34 - 40
  • [8] ABSOLUTE REQUIREMENT FOR COMPLEMENT IN MONOCLONAL IGM ANTIBODY-MEDIATED PROTECTION AGAINST EXPERIMENTAL-INFECTION WITH TYPE-III GROUP-B STREPTOCOCCI
    SHIGEOKA, AO
    JENSEN, CL
    PINCUS, SH
    HILL, HR
    JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (01): : 63 - 70
  • [9] IMPORTANCE OF COMPLEMENT SOURCE IN BACTERICIDAL ACTIVITY OF HUMAN-ANTIBODY AND MURINE MONOCLONAL-ANTIBODY TO MENINGOCOCCAL GROUP-B POLYSACCHARIDE
    ZOLLINGER, WD
    MANDRELL, RE
    INFECTION AND IMMUNITY, 1983, 40 (01) : 257 - 264
  • [10] ROLE OF ANTIBODY AND CLASSICAL AND ALTERNATIVE COMPLEMENT PATHWAYS ON OPSONIZATION OF GROUP-B STREPTOCOCCI
    SHIGEOKA, AO
    HALL, RT
    HEMMING, VG
    HILL, HR
    PEDIATRIC RESEARCH, 1977, 11 (04) : 505 - 505
12345